Skip to main content
    Back to episode
    Episode 73 · June 4, 2026 · 48m listen · 5,479 words · ~27 min read

    The Legal Hoops and Hurdles of MedTech Commercialization with JJ Amell - Full Transcript | The Med Device Cyber Podcast

    Read the complete, searchable transcript of Episode 73 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.

    Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.

    Episode summary

    In this episode of the Med Device Cyber Podcast, host Christian Espinosa is joined by JJ Amell, CEO and Attorney at Law at Amell Law, a firm specializing in helping Medtech companies navigate the legal complexities of entering the U.S. market. With a unique background influenced by his cardiologist father and a passion for technology, Amell offers a comprehensive perspective on the legal and business hurdles that international and domestic startups face. The discussion centers on the critical importance of strategic planning for U.S. market entry, which Amell argues is the ultimate 'end game' for most Medtech developers. He emphasizes that this process is far more intricate than simply filing paperwork and warns entrepreneurs against the pitfalls of using automated services like LegalZoom or relying on AI for legal guidance, stating that these tools cannot replace the tailored advice of an expert who understands the full scope of a business's needs. Amell outlines his firm's three core service areas: international corporate structuring, business immigration, and intellectual property. He explains that these elements are deeply intertwined and must be considered cohesively from the very beginning. A significant portion of the conversation is dedicated to the strategic choice of which U.S. state to incorporate in. While acknowledging that Delaware has long been the gold standard due to its established corporate law and favorability among venture capitalists, Amell presents a compelling case for other states, particularly Texas. He cites recent Delaware case law that can be unfavorable to majority shareholders and highlights Texas as a more attractive, pro-business alternative. The hosts also explore why California, despite its high taxes and complex regulations, remains a powerful hub for innovation, attributing its resilience to its deep-rooted infrastructure, access to capital, and a strong history of tech development. Amell stresses that a successful market entry strategy requires a holistic approach, aligning the legal structure with fiscal responsibilities and immigration plans to avoid costly delays, such as being denied entry on the wrong visa type or facing unexpected tax liabilities. Furthermore, the podcast delves into the practical risks companies face, including scams targeting new businesses immediately after their information becomes public through trademark filings. This underscores the need for a trusted legal partner to manage communications and verify legitimacy. The conversation reinforces the idea that navigating the U.S. market is not a simple checklist; it's a multi-faceted challenge that demands expert navigation across legal, financial, and regulatory domains. Amell's main message is one of proactive and informed planning, urging companies to build a strong, customized legal and corporate foundation with a trusted team to ensure a smooth and successful entry into the lucrative U.S. market, thereby protecting their innovation, investment, and long-term viability.

    Key takeaways from this episode

    • Entering the U.S. market is a primary goal for many Medtech developers, but the process is filled with numerous legal, corporate, and immigration hurdles that require expert guidance.
    • Relying on automated services like LegalZoom or AI for legal tasks is risky, as they provide a one-size-fits-all solution that often fails to offer the proper legal protection and strategic advice needed for complex ventures.
    • Strategic planning from the outset is crucial. Companies should align their corporate structure, business immigration plans, and intellectual property protection early to avoid costly delays and regulatory issues.
    • The choice of U.S. state for incorporation has significant legal and financial implications. While Delaware is the traditional hub, states like Texas are becoming more competitive and may offer more favorable laws for business owners.
    • Despite high taxes and regulations causing some companies to leave (the 'Techxodus'), California remains a dominant force in innovation due to its deep-rooted infrastructure and concentration of venture capital.
    • Business immigration must be handled carefully. Attempting to operate in the U.S. on the wrong type of visa can lead to denied entry and significant disruption to business timelines.
    • Once a company's information becomes public, such as through trademark filings, they often become targets for sophisticated scams and should rely on their legal counsel to vet any inquiries.
    • A holistic approach is necessary for U.S. market entry, integrating legal, fiscal, immigration, and branding strategies to build a solid foundation and mitigate risks.

    Full episode transcript

    Page 1 of 7· Paragraphs 1 - 20
    What we're starting to see is that the end game for many medtech developers is to enter the U.S. market. Christian: It sounds like from a legal entity and visa and structure perspective, they definitely would need someone's guidance because it's not something you can easily navigate it sounds like. JJ: There's so many hoops and hurdles to U.S. market entry. Guest: Why is California such a dominant force still in the tech scene even though there's all of this red tape? JJ: So you're starting to see people migrate to other states, Florida and Texas, but the foundation of innovation, it's just so strong in California that I don't see it leaving anytime soon. If you are that entrepreneur or startup that's trying to get market to the US, could I go down to LegalZoom now and and check boxes? Sure. But you know, you're not getting the proper legal guidance. AI is a great tool, but it's not an legal expert. Christian: Hi, welcome back to another episode of the Med Device Cyber podcast. Today we have a guest, uh, JJ Amell from Amell Law coming to us from Texas. So we'll probably get a bill at the end of this episode because we are talking to a lawyer. Um, so we'll see how much the bill is. It may not, we'll have to negotiate with him. So how's it going today, JJ? JJ: It's going extremely well. A very Friday to you guys. Christian: Yes, it is Friday, we're recording on a Friday. So this is an exciting topic. I think JJ is our first lawyer or attorney we've had and he does work in med tech. Uh, so it would be, it'd be fun to talk to him and pick his brain about some of the legal challenges people face in med tech. We tend to see him at most of the med tech world events. I think you're going to be at the one coming up not too long ago or coming up here in Florida. JJ: That's right. Christian: Uh, and I think we saw you in Dubai recently. Was it the last one, wasn't it? JJ: That's correct. Yeah, back in February. Christian: Awesome. And uh, are you in Houston proper or like a suburb of Houston? JJ: Uh, we're just outside Houston. We're in an area called The Woodlands, uh, northern sub suburban area of Houston. Christian: I did one of my Iron Man triathlons in The Woodlands. I swam in that, that waterway that's like horrible, it's horrible water. It was like really dirty, but it and the roads are really bad. I remember that for the triathlon, but they just had it not too long ago. JJ: That's right. Yeah. That's right. That's one of our big events here. Christian: The Woodlands is beautiful, though. JJ: It is. It's extremely beautiful. I loved I loved uh, one of the reasons why I like being out here. I mean, I grew up in the area, uh, but one of the reasons why I chose to be in The Woodlands because of all the the nature that's here and the beautiful parks. Um, and it's very um, puts me in a place of serenity. And I like to be able to just to, you know, take a break from work, maybe even go to the park or uh, just drive around. Um, having access to nature is important to me. Christian: I agree. Uh, Melissa, my wife wants us to move to Texas at some point. Uh, her, she's got family in League City, which is a little bit south and uh, Texas City, and she has a condo in Galveston, but I don't tell her this. She but I prefer The Woodlands area better than Galveston. I don't like Galveston that much for some reason. JJ: Yeah, yeah. Yeah. She already knows that probably, but. Yeah. Yeah, well, you know, and what uh Galveston is another one of my my getaway destinations. Uh, they have great Cajun food, but you know, it's it's the beach that we have. Uh, and um, I, you know, I grew up with with access to Galveston and, you know, that's one of the places that I I love to recharge, um, and get away. Um, I I even a day uh going to the beach um is enough for me to to kind of clear my head and and get back to work. But the beach and, you know, and and nature, those are uh those are critical to to like sustain my my mental health. I'll I'll put it that way. Christian: I agree. Yeah. Awesome. So what what kind of things do you mainly help medical device manufacturers with? I know there's like intellectual property. I know you've helped us with trademarks. There's like a number of, you know, things I, I know intellectual property is a big deal. A lot of people want to protect their IP when they're coming up with a new innovation, but like what are like the main, I guess, pain points you solve for Medtech innovators from a legal perspective?
    1 / 7